[1]
Nguyen, N.H. et al. 2025. Predictive Factors of Secukinumab Response in Korean Hidradenitis Suppurativa Patients: Insights from a 48-Week Trial. Dermatology Practical & Conceptual. 15, (Oct. 2025), 5933. DOI:https://doi.org/10.5826/dpc.1504a5933.